Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of A-337 in the Management of Malignant Solid Dose

NCT06093698 is registered in ClinicalTrials.gov with ITabMed Co., Ltd. as lead sponsor.

NCT NCT06093698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06093698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of A-337 in the Management of Malignant Solid Dose
Lead sponsor
ITabMed Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 1, 2023
Completion date
December 31, 2026
Enrollment
94 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent or metastatic solid tumors